Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Calgary
$27,000.00
Regulation of cellular quiescence in adult IDH-wildtype GBM
FY 2025-26
Summary
Glioblastoma (GBM) is the most common and aggressive brain cancer in adults. Even with surgery, radiation, and chemotherapy, most patients survive just over a year. A major reason for treatment failure is a small group of GBM stem cells (GSCs) that withstand therapy and drive tumor recurrence.
Like normal stem cells, some GSCs can “fall asleep” by entering a long-lasting inactive state called quiescence. Most cancer treatments target fast-dividing cells, so these quiescent, non-dividing cells often escape therapy. After treatment, they can “wake up,” start dividing again, and regenerate the tumour. This plasticity makes glioblastoma particularly hard to treat. However, we still don’t fully understand what quiescent GSCs look like, what triggers them to wake up, or how they re-enter quiescence. Answering these questions could lead to more precise therapies and delay tumour regrowth.
We use fluorescent reporters to label quiescent and active GSCs in different colours, allowing us to track quiescent cells in real time. We will assess their growth and protein expression using single-cell sequencing. With live-cell imaging, we will monitor their movement, cell division, and transitions into and out of quiescence. We will then test compounds to identify drugs that increase or reduce quiescence and measure how the cells change after treatment. This work will help us better understand what quiescent GBM cells look like and how we can better eliminate them.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573062
Name
Yakubets Kate
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Regulation of cellular quiescence in adult IDH-wildtype GBM
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Stem Cell; Cell Cycle; Epigenetics; Glioblastoma; Quiescence
Abstract
Glioblastoma (GBM) is the most common and aggressive brain cancer in adults. Even with surgery, radiation, and chemotherapy, most patients survive just over a year. A major reason for treatment failure is a small group of GBM stem cells (GSCs) that withstand therapy and drive tumor recurrence.
Like normal stem cells, some GSCs can “fall asleep” by entering a long-lasting inactive state called quiescence. Most cancer treatments target fast-dividing cells, so these quiescent, non-dividing cells often escape therapy. After treatment, they can “wake up,” start dividing again, and regenerate the tumour. This plasticity makes glioblastoma particularly hard to treat. However, we still don’t fully understand what quiescent GSCs look like, what triggers them to wake up, or how they re-enter quiescence. Answering these questions could lead to more precise therapies and delay tumour regrowth.
We use fluorescent reporters to label quiescent and active GSCs in different colours, allowing us to track quiescent cells in real time. We will assess their growth and protein expression using single-cell sequencing. With live-cell imaging, we will monitor their movement, cell division, and transitions into and out of quiescence. We will then test compounds to identify drugs that increase or reduce quiescence and measure how the cells change after treatment. This work will help us better understand what quiescent GBM cells look like and how we can better eliminate them.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yakubets, Kate
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~